Dec 30, 2020 8:00am EST Ekso Bionics’ Stockholders Elect Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors
Nov 10, 2020 8:00am EST Ekso Bionics Announces Continued Adoption of EVO™ with Flexible Subscription-Based Order from Cloverdale Foods Company
Oct 22, 2020 8:00am EDT Ekso Bionics® to Report Third Quarter 2020 Financial Results on October 29, 2020
Sep 09, 2020 8:00am EDT Ekso Bionics to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 16, 2020
Aug 20, 2020 8:30am EDT Ekso Bionics® Unveils its Latest Assistive Exoskeleton Innovation for Industrial Use
Jul 23, 2020 8:00am EDT Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020
Jul 09, 2020 8:00am EDT Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics’ Exoskeleton Device for Rehabilitation Following Successful Trial
Jun 25, 2020 8:30am EDT Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients
